Reply to Á. Benedict et al

Affiliations

¹ Christine G. Kohn, University of Connecticut/Hartford Hospital Evidence-based Practice Center and University of Saint Joseph School of Pharmacy, Hartford, CT; Simon B. Zeichner, Winship Cancer Institute at Emory University, Atlanta, GA; Qiushi Chen, Massachusetts General Hospital, Boston, MA; Alberto J. Montero, Cleveland Clinic, Cleveland, OH; Daniel A. Goldstein, Winship Cancer Institute at Emory University, Atlanta, GA, and Rabin Medical Center, Petah Tikva, Israel; and Christopher R. Flowers, Winship Cancer Institute at Emory University, Atlanta, GA.

Comment

Christine G Kohn et al. J Clin Oncol. 2017.

. 2017 Sep 10;35(26):3086-3087.

doi: 10.1200/JCO.2017.74.5273. Epub 2017 Jul 17.

¹ Christine G. Kohn, University of Connecticut/Hartford Hospital Evidence-based Practice Center and University of Saint Joseph School of Pharmacy, Hartford, CT; Simon B. Zeichner, Winship Cancer Institute at Emory University, Atlanta, GA; Qiushi Chen, Massachusetts General Hospital, Boston, MA; Alberto J. Montero, Cleveland Clinic, Cleveland, OH; Daniel A. Goldstein, Winship Cancer Institute at Emory University, Atlanta, GA, and Rabin Medical Center, Petah Tikva, Israel; and Christopher R. Flowers, Winship Cancer Institute at Emory University, Atlanta, GA.

No abstract available

Comment on

Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR. Kohn CG, et al. J Clin Oncol. 2017 Apr 10;35(11):1194-1202. doi: 10.1200/JCO.2016.69.6336. Epub 2017 Feb 21. J Clin Oncol. 2017. PMID: 28221865 Free PMC article.
Comprehensive Reporting in Cost-Effectiveness Modeling.
Benedict Á, Ambavane A, Tarhini A. Benedict Á, et al. J Clin Oncol. 2017 Sep 10;35(26):3085-3086. doi: 10.1200/JCO.2017.73.6355. Epub 2017 Jul 17. J Clin Oncol. 2017. PMID: 28715247 No abstract available.